CAPPED BONUSZERTIFIKAT - FRESENIUS MEDICAL CARE Stock

Certificat

DE000PC2GJX4

Market Closed - Boerse Frankfurt Warrants 15:40:18 2024-05-24 EDT
49.18 EUR +1.24% Intraday chart for CAPPED BONUSZERTIFIKAT - FRESENIUS MEDICAL CARE
Current month+3.89%
1 month+4.73%
Date Price Change
24-05-24 49.18 +1.24%
24-05-23 48.58 -0.59%
24-05-22 48.87 -0.85%
24-05-21 49.29 -0.82%
24-05-20 49.7 +0.40%

Real-time Boerse Frankfurt Warrants

Last update May 24, 2024 at 03:40 pm

More quotes

Static data

Product typeBonus- and Part-Guarantee-Certificates
Buy / SellCALL
Underlying FRESENIUS MEDICAL CARE AG
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC2GJX
ISINDE000PC2GJX4
Date issued 2023-12-19
Strike 54
Maturity 2025-03-21 (299 Days)
Parity 1 : 1
Emission price 39.88
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 50.14
Lowest since issue 40.52
Spread 0.22
Spread %0.44%

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
39 EUR
Average target price
39.84 EUR
Spread / Average Target
+2.16%
Consensus